The FDA has approved the first prescription, at-home neuromodulation therapy for individuals with major depressive disorder ...

The wearable device delivers electrical impulses through a headset that can be administered by the patient at home under ...

PARK CITY, Utah--(BUSINESS WIRE)--BlueWind Medical, Ltd., a leader in implantable Tibial Neuromodulation (iTNM) and developer of the Revi® System, a patient-centric solution for urge urinary ...

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.

CORAL SPRINGS, Fla., Jan. 12, 2026 /PRNewswire/ -- Neurolief Inc., a medical device company focused on neuromodulation therapies for neuropsychiatric conditions, today announced that the U.S. Food and ...

The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment ...

For individuals with major depressive disorder (MDD) that does not respond to pharmacotherapy, recent decisions by the U.S.

With its expansion into St. Louis, Restore Brain continues its mission to broaden access to advanced psychiatric treatments ...

This post was co-authored by Abigail Ramos and Robert T. Muller, Ph.D. With the development of new neuro-technology and emerging research on the function of the brain, the treatment of mental illness ...

SEOUL, South Korea--(BUSINESS WIRE)--Professor Kim Jae-ho of the Department of Neurology at Hallym University Dongtan Sacred Heart Hospital delivered a presentation titled “Transcranial Focused ...